HEADER HYDROLASE 09-SEP-19 6SSZ TITLE STRUCTURE OF THE PLASMODIUM FALCIPARUM FALCIPAIN 2 PROTEASE IN COMPLEX TITLE 2 WITH AN (E)-CHALCONE INHIBITOR. COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYSTEINE PROTEINASE FALCIPAIN 2A; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: FALCIPAIN 2; COMPND 5 EC: 3.4.22.-; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: FEATURES A C25A MUTATION USING THE NUMBERING SYSTEM OF COMPND 9 THE ENTRY. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_TAXID: 5833; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS INHIBITOR, COMPLEX, MALARIA, HAEMOGLOBIN, PROTEOLYSIS, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.MACHIN,A.KANTSADI,I.VAKONAKIS REVDAT 3 24-JAN-24 6SSZ 1 REMARK REVDAT 2 11-DEC-19 6SSZ 1 JRNL REVDAT 1 04-DEC-19 6SSZ 0 JRNL AUTH J.M.MACHIN,A.L.KANTSADI,I.VAKONAKIS JRNL TITL THE COMPLEX OF PLASMODIUM FALCIPARUM FALCIPAIN-2 PROTEASE JRNL TITL 2 WITH AN (E)-CHALCONE-BASED INHIBITOR HIGHLIGHTS A NOVEL, JRNL TITL 3 SMALL, MOLECULE-BINDING SITE. JRNL REF MALAR.J. V. 18 388 2019 JRNL REFN ESSN 1475-2875 JRNL PMID 31791339 JRNL DOI 10.1186/S12936-019-3043-0 REMARK 2 REMARK 2 RESOLUTION. 3.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 94.77 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 59.2 REMARK 3 NUMBER OF REFLECTIONS : 5712 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM SELECTION REMARK 3 R VALUE (WORKING + TEST SET) : 0.258 REMARK 3 R VALUE (WORKING SET) : 0.255 REMARK 3 FREE R VALUE : 0.308 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 288 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3793 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 147.8 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: AUTOMATICALLY APPLIED NCS AND TLS REMARK 3 RESTRAINTS. REFINED USING RCSB 2OUL AS EXTERNAL TARGET RESTRAINT. REMARK 4 REMARK 4 6SSZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-SEP-19. REMARK 100 THE DEPOSITION ID IS D_1292104250. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-JAN-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6001 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.450 REMARK 200 RESOLUTION RANGE LOW (A) : 94.770 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.2 REMARK 200 DATA REDUNDANCY : 18.90 REMARK 200 R MERGE (I) : 0.20400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 66.9 REMARK 200 DATA REDUNDANCY IN SHELL : 17.60 REMARK 200 R MERGE FOR SHELL (I) : 2.31000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2OUL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MOTHER LIQUOR COMPRISING 0.12 M OF REMARK 280 MONOSACCHARIDES MIXTURE (D-GLUCOSE; D-MANNOSE; D-GALACTOSE; L- REMARK 280 FUCOSE; D-XYLOSE; N-ACETYL-D-GLUCOSAMINE), 0.1 M TRIS/BICINE (PH REMARK 280 8.5); 20% V/V GLYCEROL, 10% W/V PEG 4000. CRYSTAL SOAKED FOR 2 REMARK 280 HOURS WITH (E)-CHALCONE #48 INHIBITOR. INHIBITOR PREPARED IN 100% REMARK 280 DMSO, 100 MM CONCENTRATION AND THEN DILUTED TO 1 MM IN MOTHER REMARK 280 LIQUOR FOR CRYSTAL SOAKING., VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 71.50267 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 35.75133 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 35.75133 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 71.50267 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -18 REMARK 465 GLY B -18 REMARK 465 PRO B -17 REMARK 465 ILE B 223 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 63 -4.49 65.22 REMARK 500 SER A 91 -132.40 51.66 REMARK 500 LEU A 173 -61.22 -91.28 REMARK 500 SER A 188 53.82 -91.30 REMARK 500 CYS B 63 -2.44 78.29 REMARK 500 SER B 91 -131.72 51.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue JV1 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue JV1 B 301 DBREF 6SSZ A -16 223 UNP Q9N6S8 Q9N6S8_PLAFA 244 483 DBREF 6SSZ B -16 223 UNP Q9N6S8 Q9N6S8_PLAFA 244 483 SEQADV 6SSZ GLY A -18 UNP Q9N6S8 EXPRESSION TAG SEQADV 6SSZ PRO A -17 UNP Q9N6S8 EXPRESSION TAG SEQADV 6SSZ ALA A 25 UNP Q9N6S8 CYS 285 ENGINEERED MUTATION SEQADV 6SSZ GLY B -18 UNP Q9N6S8 EXPRESSION TAG SEQADV 6SSZ PRO B -17 UNP Q9N6S8 EXPRESSION TAG SEQADV 6SSZ ALA B 25 UNP Q9N6S8 CYS 285 ENGINEERED MUTATION SEQRES 1 A 242 GLY PRO GLN MET ASN TYR GLU GLU VAL ILE LYS LYS TYR SEQRES 2 A 242 ARG GLY GLU GLU ASN PHE ASP HIS ALA ALA TYR ASP TRP SEQRES 3 A 242 ARG LEU HIS SER GLY VAL THR PRO VAL LYS ASP GLN LYS SEQRES 4 A 242 ASN CYS GLY SER ALA TRP ALA PHE SER SER ILE GLY SER SEQRES 5 A 242 VAL GLU SER GLN TYR ALA ILE ARG LYS ASN LYS LEU ILE SEQRES 6 A 242 THR LEU SER GLU GLN GLU LEU VAL ASP CYS SER PHE LYS SEQRES 7 A 242 ASN TYR GLY CYS ASN GLY GLY LEU ILE ASN ASN ALA PHE SEQRES 8 A 242 GLU ASP MET ILE GLU LEU GLY GLY ILE CYS PRO ASP GLY SEQRES 9 A 242 ASP TYR PRO TYR VAL SER ASP ALA PRO ASN LEU CYS ASN SEQRES 10 A 242 ILE ASP ARG CYS THR GLU LYS TYR GLY ILE LYS ASN TYR SEQRES 11 A 242 LEU SER VAL PRO ASP ASN LYS LEU LYS GLU ALA LEU ARG SEQRES 12 A 242 PHE LEU GLY PRO ILE SER ILE SER VAL ALA VAL SER ASP SEQRES 13 A 242 ASP PHE ALA PHE TYR LYS GLU GLY ILE PHE ASP GLY GLU SEQRES 14 A 242 CYS GLY ASP GLN LEU ASN HIS ALA VAL MET LEU VAL GLY SEQRES 15 A 242 PHE GLY MET LYS GLU ILE VAL ASN PRO LEU THR LYS LYS SEQRES 16 A 242 GLY GLU LYS HIS TYR TYR TYR ILE ILE LYS ASN SER TRP SEQRES 17 A 242 GLY GLN GLN TRP GLY GLU ARG GLY PHE ILE ASN ILE GLU SEQRES 18 A 242 THR ASP GLU SER GLY LEU MET ARG LYS CYS GLY LEU GLY SEQRES 19 A 242 THR ASP ALA PHE ILE PRO LEU ILE SEQRES 1 B 242 GLY PRO GLN MET ASN TYR GLU GLU VAL ILE LYS LYS TYR SEQRES 2 B 242 ARG GLY GLU GLU ASN PHE ASP HIS ALA ALA TYR ASP TRP SEQRES 3 B 242 ARG LEU HIS SER GLY VAL THR PRO VAL LYS ASP GLN LYS SEQRES 4 B 242 ASN CYS GLY SER ALA TRP ALA PHE SER SER ILE GLY SER SEQRES 5 B 242 VAL GLU SER GLN TYR ALA ILE ARG LYS ASN LYS LEU ILE SEQRES 6 B 242 THR LEU SER GLU GLN GLU LEU VAL ASP CYS SER PHE LYS SEQRES 7 B 242 ASN TYR GLY CYS ASN GLY GLY LEU ILE ASN ASN ALA PHE SEQRES 8 B 242 GLU ASP MET ILE GLU LEU GLY GLY ILE CYS PRO ASP GLY SEQRES 9 B 242 ASP TYR PRO TYR VAL SER ASP ALA PRO ASN LEU CYS ASN SEQRES 10 B 242 ILE ASP ARG CYS THR GLU LYS TYR GLY ILE LYS ASN TYR SEQRES 11 B 242 LEU SER VAL PRO ASP ASN LYS LEU LYS GLU ALA LEU ARG SEQRES 12 B 242 PHE LEU GLY PRO ILE SER ILE SER VAL ALA VAL SER ASP SEQRES 13 B 242 ASP PHE ALA PHE TYR LYS GLU GLY ILE PHE ASP GLY GLU SEQRES 14 B 242 CYS GLY ASP GLN LEU ASN HIS ALA VAL MET LEU VAL GLY SEQRES 15 B 242 PHE GLY MET LYS GLU ILE VAL ASN PRO LEU THR LYS LYS SEQRES 16 B 242 GLY GLU LYS HIS TYR TYR TYR ILE ILE LYS ASN SER TRP SEQRES 17 B 242 GLY GLN GLN TRP GLY GLU ARG GLY PHE ILE ASN ILE GLU SEQRES 18 B 242 THR ASP GLU SER GLY LEU MET ARG LYS CYS GLY LEU GLY SEQRES 19 B 242 THR ASP ALA PHE ILE PRO LEU ILE HET JV1 A 301 22 HET JV1 B 301 22 HETNAM JV1 (~{E})-3-(1,3-BENZODIOXOL-5-YL)-1-(3-NITROPHENYL)PROP- HETNAM 2 JV1 2-EN-1-ONE FORMUL 3 JV1 2(C16 H11 N O5) HELIX 1 AA1 ASN A -14 ARG A -5 1 10 HELIX 2 AA2 ARG A 8 SER A 11 5 4 HELIX 3 AA3 SER A 24 LYS A 42 1 19 HELIX 4 AA4 SER A 49 SER A 57 1 9 HELIX 5 AA5 LEU A 67 GLY A 79 1 13 HELIX 6 AA6 LYS A 118 GLY A 127 1 10 HELIX 7 AA7 SER A 136 PHE A 141 1 6 HELIX 8 AA8 ARG A 210 LEU A 214 5 5 HELIX 9 AA9 ASN B -14 ARG B -5 1 10 HELIX 10 AB1 ARG B 8 SER B 11 5 4 HELIX 11 AB2 SER B 24 LYS B 42 1 19 HELIX 12 AB3 SER B 49 SER B 57 1 9 HELIX 13 AB4 LEU B 67 GLY B 79 1 13 HELIX 14 AB5 LYS B 118 GLY B 127 1 10 HELIX 15 AB6 SER B 136 PHE B 141 1 6 HELIX 16 AB7 ARG B 210 LEU B 214 5 5 SHEET 1 AA1 5 TYR A 5 ASP A 6 0 SHEET 2 AA1 5 HIS A 157 VAL A 170 -1 O PHE A 164 N TYR A 5 SHEET 3 AA1 5 ILE A 129 VAL A 133 -1 N ILE A 129 O LEU A 161 SHEET 4 AA1 5 ALA A 218 LEU A 222 -1 O PHE A 219 N SER A 130 SHEET 5 AA1 5 ASN A 110 SER A 113 -1 N ASN A 110 O LEU A 222 SHEET 1 AA2 5 TYR A 5 ASP A 6 0 SHEET 2 AA2 5 HIS A 157 VAL A 170 -1 O PHE A 164 N TYR A 5 SHEET 3 AA2 5 GLY A 177 LYS A 186 -1 O LYS A 186 N MET A 160 SHEET 4 AA2 5 PHE A 198 THR A 203 -1 O ILE A 201 N TYR A 183 SHEET 5 AA2 5 ILE A 146 PHE A 147 1 N PHE A 147 O ASN A 200 SHEET 1 AA3 5 TYR B 5 ASP B 6 0 SHEET 2 AA3 5 HIS B 157 VAL B 170 -1 O PHE B 164 N TYR B 5 SHEET 3 AA3 5 ILE B 129 VAL B 133 -1 N ILE B 129 O LEU B 161 SHEET 4 AA3 5 ALA B 218 LEU B 222 -1 O PHE B 219 N SER B 130 SHEET 5 AA3 5 ASN B 110 SER B 113 -1 N ASN B 110 O LEU B 222 SHEET 1 AA4 5 TYR B 5 ASP B 6 0 SHEET 2 AA4 5 HIS B 157 VAL B 170 -1 O PHE B 164 N TYR B 5 SHEET 3 AA4 5 GLY B 177 LYS B 186 -1 O ILE B 184 N GLY B 163 SHEET 4 AA4 5 PHE B 198 THR B 203 -1 O ILE B 201 N TYR B 183 SHEET 5 AA4 5 ILE B 146 PHE B 147 1 N PHE B 147 O ASN B 200 SSBOND 1 CYS A 22 CYS A 63 1555 1555 2.05 SSBOND 2 CYS A 56 CYS A 97 1555 1555 2.03 SSBOND 3 CYS A 82 CYS A 102 1555 1555 2.04 SSBOND 4 CYS A 151 CYS A 212 1555 1555 2.04 SSBOND 5 CYS B 22 CYS B 63 1555 1555 2.05 SSBOND 6 CYS B 56 CYS B 97 1555 1555 2.03 SSBOND 7 CYS B 82 CYS B 102 1555 1555 2.05 SSBOND 8 CYS B 151 CYS B 212 1555 1555 2.05 SITE 1 AC1 2 CYS A 22 ALA A 140 SITE 1 AC2 1 ALA B 140 CRYST1 109.431 109.431 107.254 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009138 0.005276 0.000000 0.00000 SCALE2 0.000000 0.010552 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009324 0.00000